ReviewEcancermedicalscience2019

Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab.

Carlos Henrique Barrios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.